Development and subsequent refinement of the inflammatory bowel disease questionnaire: A quality-of-life instrument for adult patients with inflammatory bowel disease

被引:134
作者
Irvine, EJ [1 ]
机构
[1] McMaster Univ, Dept Med, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada
关键词
Crohn's disease; health status instrument; index of health; office practice; quality of life; questionnaire; ulcerative colitis;
D O I
10.1097/00005176-199904001-00003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Health-related quality of life (HRQOL) describes the physical, social, and emotional attitudes and behavior of people in relation to health status. By the 1980s, HRQOL was noted to be impaired in chronic diseases but inflammatory bowel disease, had not been extensively described. Methods: This review summarizes the results of several studies describing the development and application of a disease-specific HRQOL instrument, the Inflammatory Bowel Disease Questionnaire (IBDQ). Results: An initial study described how patients with inflammatory bowel disease identified 150 problems they had experienced in four domains: bowel, systemic, emotional, and social function. Almost half of patients underreported impairment until encouraged by a reminder list. Thirty-two questions were included in the final questionnaire and were scored on a 7-point scale from 1 (worst) to 7 (best) for a range of possible scores from 32 to 224. Physicians' and spouses' global assessments correlated poorly with patient-reported HRQOL. Subsequent validation of the IBDQ suggested a strong correlation with disease severity (r = -0.5; p < 0.001) and a test-retest reliability of 0.7. Mean score changes of 16 to 30 points have been linked to changes in therapy. Statistically significant differences also occur between active and inactive disease. Results of four clinical trials have included the IBDQ as a measure of outcome. A self-administered version and a shortened version of the IBDQ have also been validated. Conclusions: The IBDQ is a valid, reliable, and sensitive measure that can be meaningfully applied in clinical trials. The short IBDQ may also be useful in clinical research and office practice.
引用
收藏
页码:S23 / S27
页数:5
相关论文
共 14 条
[1]  
[Anonymous], 1990, CAN J GASTROENTEROL, DOI DOI 10.1155/1990/659079
[2]   LOW-DOSE CYCLOSPORINE FOR THE TREATMENT OF CROHNS-DISEASE [J].
FEAGAN, BG ;
MCDONALD, JWD ;
ROCHON, J ;
LAUPACIS, A ;
FEDORAK, RN ;
KINNEAR, D ;
SAIBIL, F ;
GROLL, A ;
ARCHAMBAULT, A ;
GILLIES, R ;
VALBERG, B ;
IRVINE, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (26) :1846-1851
[3]   METHOTREXATE FOR THE TREATMENT OF CROHNS-DISEASE [J].
FEAGAN, BG ;
ROCHON, J ;
FEDORAK, RN ;
IRVINE, EJ ;
WILD, G ;
SUTHERLAND, L ;
STEINHART, AH ;
GREENBERG, GR ;
GILLIES, R ;
HOPKINS, M ;
HANAUER, SB ;
MCDONALD, JWD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (05) :292-297
[4]   QUALITY-OF-LIFE MEASURES IN HEALTH-CARE .1. APPLICATIONS AND ISSUES IN ASSESSMENT [J].
FITZPATRICK, R ;
FLETCHER, A ;
GORE, S ;
JONES, D ;
SPIEGELHALTER, D ;
COX, D .
BRITISH MEDICAL JOURNAL, 1992, 305 (6861) :1074-1077
[5]   ORAL BUDESONIDE FOR ACTIVE CROHNS-DISEASE [J].
GREENBERG, GR ;
FEAGAN, BG ;
MARTIN, F ;
SUTHERLAND, LR ;
THOMSON, ABR ;
WILLIAMS, CR ;
NILSSON, LG ;
PERSSON, T ;
BAIN, V ;
CHERRY, R ;
FEDORAK, R ;
LALOR, E ;
SHERBANIUK, R ;
YACYSHYN, B ;
KIERDEKIS, P ;
BAILEY, R ;
MEYER, D ;
FREEMAN, H ;
DAWS, P ;
HOLLAND, S ;
BUYTENDORP, M ;
WHITTAKER, S ;
CHANG, A ;
SUTHERLAND, L ;
HERSHFIELD, N ;
MACCANNELL, K ;
MEDDING, J ;
PRICE, L ;
SHAFFER, E ;
RACICOT, N ;
BASS, S ;
BRIDGES, R ;
BLUSTEIN, P ;
LAY, T ;
VANROSENDAAL, G ;
WATSON, M ;
WILLIAMS, CN ;
VANZANTEN, V ;
LEDDIN, D ;
FALKENHAM, J ;
TANTON, R ;
HUMAN, P ;
TURNBALL, G ;
SCHEP, G ;
WOOLNOUGH, J ;
DALLAIRE, C ;
ROSSEAU, B ;
BERNARD, F ;
DUBE, R ;
PARE, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (13) :836-841
[6]   A NEW MEASURE OF HEALTH-STATUS FOR CLINICAL-TRIALS IN INFLAMMATORY BOWEL-DISEASE [J].
GUYATT, G ;
MITCHELL, A ;
IRVINE, EJ ;
SINGER, J ;
WILLIAMS, N ;
GOODACRE, R ;
TOMPKINS, C .
GASTROENTEROLOGY, 1989, 96 (03) :804-810
[7]   MEASURING CHANGE OVER TIME - ASSESSING THE USEFULNESS OF EVALUATIVE INSTRUMENTS [J].
GUYATT, G ;
WALTER, S ;
NORMAN, G .
JOURNAL OF CHRONIC DISEASES, 1987, 40 (02) :171-178
[8]   MEASURING HEALTH-RELATED QUALITY-OF-LIFE [J].
GUYATT, GH ;
FEENY, DH ;
PATRICK, DL .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (08) :622-629
[9]  
IRVINE EJ, 1994, GASTROENTEROLOGY, V106, pA517
[10]   QUALITY-OF-LIFE - A VALID AND RELIABLE MEASURE OF THERAPEUTIC EFFICACY IN THE TREATMENT OF INFLAMMATORY DOWEL DISEASE [J].
IRVINE, EJ ;
FEAGAN, B ;
ROCHON, J ;
ARCHAMBAULT, A ;
FEDORAK, RN ;
GROLL, A ;
KINNEAR, D ;
SAIBIL, F ;
MCDONALD, JWD ;
VALBERG, B ;
LAUPACIS, A ;
RIDDELL, R ;
SEATON, T ;
SOMERS, S ;
DIRKS, J ;
FEUTREN, G ;
JEEJEEBHOY, K ;
SACKETT, D ;
DANDAVINO, R ;
GHENT, CN ;
GRYNOCH, JR ;
HOLBROOK, AM ;
KIBERD, BA ;
KNETEMAN, N ;
LEVINE, M ;
MANUEL, M ;
MUIRHEAD, NN ;
SAIPHOO, CS ;
SOMERVILLE, PJ ;
CAMERON, L ;
LOCKWOOD, T ;
SEGLENIEKS, E ;
TAYLORDOLMER, K ;
CHERRY, R ;
FISHER, D ;
KIRDEIKIS, P ;
MAHACHAI, V ;
SEDENS, T ;
SHERBANIUK, R ;
THOMSON, A ;
WENSEL, R ;
CASTELLI, M ;
COLLINS, S ;
CROITORU, K ;
CROWE, S ;
DONNELLY, M ;
GOODACRE, R ;
HUNT, R ;
LUMB, B ;
ROSSMAN, R .
GASTROENTEROLOGY, 1994, 106 (02) :287-296